The name “Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA)” was proposed to underline their distinctiveness in pathogenesis and clinical behavior [26]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).